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Abstract
Although serotonin is known to play an important role in pain processing, the relationship
between the polymorphism in 5-HTTLPR and pain processing is not well understood. To
examine the relationship more comprehensively, various factors of pain processing having
putative associations with 5-HT functioning were studied, namely the subjective pain experi-
ence (pain threshold, rating of experimental pain), catastrophizing about pain (Pain Cata-
strophizing Scale = PCS) and motor responsiveness (facial expression of pain). In 60
female and 67 male participants, heat pain stimuli were applied by a contact thermode to
assess pain thresholds, supra-threshold ratings and a composite score of pain-relevant
facial responses. Participants also completed the PCS and were grouped based on their 5-
HTTLPR genotype (bi-allelic evaluation) into a group with s-allele carriers (ss, sl) and a sec-
ond group without (ll). S-allele carriers proved to have lower pain thresholds and higher
PCS scores. These two positive findings were unrelated to each other. No other difference
between genotype groups became significant. In all analyses, “age” and “gender” were con-
trolled for. In s-allele carriers the subjective pain experience and the tendency to catastro-
phize about pain was enhanced, suggesting that the s-allele might be a risk factor for the
development and maintenance of pain. This risk factor seems to act via two independent
routes, namely via the sensory processes of subjective pain experiences and via the
booster effects of pain catastrophizing.
Introduction
Serotonin (5-HT) has appeared to be involved in nociception and pain processing in multiple
ways at peripheral and central levels [1]. Although a general link is by all means proven, it is
much more difficult to tell exactly via which mechanisms and at which sites 5-HT unfolds its
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action. Molecular and systemic approaches have been developed to scrutinize the action of
5-HT. The systemic approaches are often based on the idea that in 5-HT synapses the availabil-
ity of 5-HT determines its functionality, which is in turn dependent on the release, enzymatic
cleavage and reuptake of 5-HT. Factors with great relevance for the functionality of 5-HT syn-
apses are 5-HT transporters that recycle 5-HT into the presynaptic terminal. It depends on the
genetic make-up how efficient these 5-HT transporters work. An intensively studied polymor-
phism is the serotonin transporter gene-linked polymorphic region (5-HTTLPR). A deletion/
insertion in the 5-HTTLPR creates a short (s) allele and a long (l) allele (14- and 16-repeat
alleles), which alters the promoter activity, with the short allele being associated with reduced
transcriptional efficiency and thus, reduced 5-HT reuptake activity [2]. Systemic effects of
these allele types have mainly been studied for psychiatric disorders such as anxiety and
depression with mixed results [3].
There have also been a few attempts to relate the 5-HTTLPR polymorphism to pain process-
ing. Most studies have focused on the subjective pain experience by assessing differences in
pain thresholds. Whereas most of these studies found no effects of the 5-HTTLPR polymor-
phism on pain thresholds [4,5,6]; Hooten et al. [7] and Lindstedt et al. [8] observed that indi-
viduals with at least one short allele appeared to be less pain sensitive. However, the direct
effects have appeared to be small and inconsistent.
A clearer picture of the effect of 5-HTTLPR polymorphism on pain processing might be
obtained by not only assessing the subjective pain experience but by considering in addition
various booster factors of pain processing that are also supposed to be 5-HT related. One such
booster factor is the emotional appraisal of pain. The consequences of such emotional appraisal
processes, like anxiety and depression, have repeatedly been shown to be related to 5-HTTLPR
on the one hand [3] and have pain enhancing effects on the other hand [9]. According to such
considerations, it is not surprising that chronic pain syndromes with a high emotional load
have shown association with the short allele of 5-HTTLPR [10]. Thus, we decided to study
pain catastrophizing as one booster factor of pain processing, given its relevance in emotional
appraisal processes of pain and given its proven influence on pain processing (also in pain
patients) [11].
Besides studying pain catastrophizing, we were also interested in a booster factor that might
not appear compelling at first glance. Pain processing is also accompanied by motor respon-
siveness. This motor responsiveness is not only triggered by the intensity of pain but is also
under the control of inhibitory regulation. We use the term “inhibition” to relate to the behav-
ioral impulse control by prefrontal inhibitory circuits, which have appeared to be related 5-HT
functioning [12], and not to the descending systems of pain inhibition. In line with this, Landro
et al. [13] could demonstrate that persons with a short allele in 5-HTTLPR showed poorer per-
formance in behavioral inhibition. This type of behavioral inhibition has been shown to be
reflected in the facial expression of pain. It is known that we tend to inhibit our facial expres-
sions of pain [14] and that facial stoicism (while experiencing pain) is due to strong inhibitory
control of facial expressions and not a lack of subjective pain experience [15]. Interestingly, this
behavioral inhibition of facial expression feeds back to influence the processing of pain [14].
In summary, we studied the association of 5-HTTLPR polymorphisms with (i) the subjec-
tive pain experience by assessing pain threshold and supra-threshold pain ratings and (ii) with
two additional booster factors of pain processing, namely pain catastrophizing and motor
responsiveness to pain (facial expression of pain) in a large sample of pain-free individuals.
The three factors were methodologically designed to avoid any redundancy of variables and led
to independent perspectives on pain processing. The pattern of associations should be informa-
tive about some of the mechanisms of 5-HT related actions on the pain systems.
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Materials and Methods
Participants
127 healthy volunteers (female: N = 60, male: N = 67) between the ages of 18 and 65 years
(mean age 36.3 years; SD = 14.9) participated in this study. Participants were recruited via
advertisements in the local newspaper (Bamberg) and via advertisements posted at the cam-
pus of the University of Bamberg. Exclusion criteria were current experience of acute or
chronic pain, psychological or physical illnesses and paresthesia or other types of somatosen-
sory dysfunctions affecting the left lower leg (site of stimulation). Participants taking psycho-
tropic drugs or analgesics were excluded from participation as well. All participants provided
written informed consent and received monetary compensation. The study protocol (includ-
ing the consent procedure) was approved by the Ethics committee of the University of
Bamberg.
Procedure
The experiment consisted of two testing sessions that were conducted on separate days. In the
first session pain threshold, subjective and facial responses to heat pain as well as the degree of
pain catastrophizing were assessed. In a second session (which took place several weeks till up
to several months later) participants returned to the lab and bucca cells were sampled for
5-HTTLPR genotyping.
Pain induction and assessment of the subjective experience of pain. Thermal stimula-
tion was applied on the outer part of the left lower leg by a Peltier based contact stimulation
device (Medoc, TSA-2001, Ramat Yishai, Israel) with a 30 mm  30 mm contact thermode.
Assessment of pain thresholds: The first session started with the assessment of individuals’
pain threshold. Heat pain thresholds were determined using the method of adjustment. Partici-
pants were asked to adjust a temperature starting from 38°C, using heating and cooling but-
tons, until they obtained a level which was barely painful. A constant press of the buttons
produced a heating or cooling rate of 0.5°C/s. Following three familiarization trial, there were 4
trials and the average of these trials was used to constitute the threshold estimate.
Heat stimulation for assessing supra-threshold pain ratings (and facial expressions of pain):
Following the assessment of pain thresholds, heat stimuli (5s (plateau); rate of change: 4°C/s;
baseline temperature: 38°C; inter-stimulus-intervals of 15-20s) were applied to the lower leg.
Two different stimulus intensities were applied, namely painful (+3°C above the pain thresh-
old) as well as non-painful (-3°C below the pain threshold) intensities. Applying non-painful
intensities allows determining which types of facial responses are indeed specific for painful
experiences. Participants received 10 painful and 10 non-painful stimuli in a random order.
The reason why we chose temperature intensities that were tailored to the individual pain
threshold instead of fixed intensities was that we wanted to assess individual differences in
supra-threshold pain ratings (and in facial expressiveness) that are not simply due to differ-
ences in pain threshold sensitivity.
Assessment of supra-threshold self-report ratings: Participants were asked to provide self-
report ratings using an electronic visual analogue scale (VAS; 100mm) after each heat stimulus.
The scale was labeled with a verbal anchor of ‘‘slightly painful” in the center so that all non-
painful sensations should be rated below and all painful ones above. Participants were told that
the left and right ends of the scale corresponded to “no sensation” and “extremely strong pain”,
respectively. Participants had to rate the intensity of their non-painful and painful experiences
by moving a cursor to the right or left and thereby choosing one location on the scale. Ratings
had to be given within 10s after stimulus offset.
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Assessing facial expressions of pain. The face of the participants was videotaped through-
out the pain induction procedure. The camera was located approximately 1.0–2.0 m from the
participant and participants were informed about the video recording. In order to enable off-
line segmentation of the videos, a LED visible to the camera, but not to the participant, was lit
concurrently with the 5 s-thermal stimulation, starting when the target temperature had been
reached. Participants were instructed to keep and upright position and not to talk during ther-
mal stimulation
Facial expressions were coded from the video recordings using the Facial Action Coding
System [16], which is based on anatomical analysis of facial movements and distinguishes 44
different Action Units (AUs) produced by single muscles or combinations of muscles. Four
coders, trained by a certified FACS coder (qualified by passing an examination given by the
developers of the system) identified the frequency and the intensity (5-point scale) of the differ-
ent Action Units. Calculation of interrater reliability was based on 5% of the video recordings
using the Ekman–Friesen formula [16] and lay between 0.82–0.87, which compares favourably
with other research in the FACS literature. A software designed for the analysis of observational
data (the Observer Video-Pro; Noldus Information Technology) was used to segment the vid-
eos and to enter the FACS codes into a time-related database. Time segments of 7 s beginning
just after stimulus had reached the target temperature (5 seconds of plateau intensity + 2 sec-
onds during temperature offset) were selected for scoring. In total 10 non-painful and 10 pain-
ful segments were analyzed in each participant. For the purpose of necessary data reduction,
we combined those AUs that represent facial movements of similar muscles as has been done
in preceding studies without any loss of information (e.g. Prkachin, 1992). Those combinations
include AU1/2, AU6/7, AU9/10 and AU25/26/27. As was done in previous studies [14,17,18],
pain-relevant AUs were selected using the following stepwise approach: (1) AUs had to occur
in more than 5% of the painful segments recorded and (2) AUs had to be more frequent during
pain than during non-painful segments (effect size d0.5; these AUs are shaded in grey in
Table 1). In the present study, brow lowering (contraction of the eyebrows), orbit tightening
(contraction of the muscles surrounding the eyes), levator contraction (raising the upper lip
and wrinkling the nose) and mouth opening (opening the mouth) proved to be pain-relevant
AUs. Mean AU-frequency and mean AU-intensity values of these selected AUs were combined
(product terms) to form a composite score of pain-relevant facial responses [17]. Due to the fact
that these composite scores were not distributed normally, square root transformed scores were
used for further analyses.
Table 1. Selection of pain-relevant facial responses: Facial Action Units (AUs) with a critical occurrence of more than 5% during painful stimula-
tion are listed. Frequency of occurrence and effect sizes for frequency differences between “non-painful” and “painful” segments are given.
Action Unit Description Frequency of occurence
Percenta Effect size (Cohen’s d)
AU1/2 brow raiser 12.2 d = 0.29
AU4 brow lower 22.1 d = 0.69
AU6/7 orbit tightening 41.0 d = 0.70
AU9/10 levator contraction 14.7 d = 0.52
AU14 dimpler 11.3 d = 0.30
AU25/26/27 mouth opening 21.7 d = 0.52
Medium and strong effect sizes (d  0.5) are marked in bold.
a percent denotes the percentage of occurrence in the entire painful segments (10 painful heat stimuli).
doi:10.1371/journal.pone.0153089.t001
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Pain catastrophizing. A German translation of the Pain Catastrophizing Scale was used
to assess catastrophic thinking related to pain (PCS [19,20]). Participants are instructed to
reflect on thoughts or feelings during the past painful experiences. The scale contains 13 items
that are rated on a five-point scale, with the end points ‘‘not at all” and ‘‘all the time”. For fur-
ther analysis, the sum score was entered. The PCS has been widely used in research on pain cat-
astrophizing, and has been shown to have high internal consistency. Pain catastrophizing is
highly relevant in emotional appraisal of pain processes.
Genotyping. DNA was extracted from buccal cells using a standard commercial extraction
kit (High Pure PCR Template Preparation Kit; Roche, Mannheim, Germany) in a MagNA
Pure LC System (Roche). Genotyping for the classification of the 5-HTTLPR (to distinguish
genotypes of s/s, s/l and l/l) was performed at the University of Giessen (Germany) as described
previously by Alexander et al. [21]. Given that in previous studies the s-allele has been mostly
linked to changes in pain sensitivity as well as to chronic pain conditions, we compared s-allele
carriers (S/S, S/L) with individuals carrying no s-allele (L/L).
Statistics
To test for effects of 5-HTTLPR genotype on pain thresholds and on pain catastrophizing, we
conducted analysis of covariance (ANCOVA) with one between-subject factor “genotype” (s/s
and s/l vs. no s-allele) and adding “age” and “gender” as covariates. The effects of 5-HTTLPR
genotype on facial responses and pain ratings was assessed using ANCOVA with repeated
measurement with one within “stimulus intensity” (non-painful vs. painful heat), one between-
subject factor “genotype” ((s/s and s/l) vs. no s-allele) and adding “age” and “gender” as
covariates.
Findings were considered to be statistically significant at α<0.05. SPSS-22 was used for all
analyses.
Results
Genotypes–sample characteristics
Sample characteristics are depicted in Table 2. Groups separated by 5-HTTLPR genotype (s-
allele carriers (s/l and s/s) versus no s-allele carriers (l/l)) did not differ significantly with
respects to age and gender. Moreover, there was no significant deviation from Hardy—Wein-
berg-Equilibrium (x2 = 1.34 df = 1, p = 0.25).
Subjective pain sensitivity
Pain thresholds differed significantly between groups with s-allele vs. no s-allele (F(1,123) =
4.53, p = 0.035), when adjusting for age and gender. As can be seen in Fig 1, s-allele carriers
showed significantly reduced pain thresholds.
With regard to VAS ratings of the non-painful and supra-threshold painful heat stimuli,
5-HTTLPR genotype groups did not differ in their ratings (F(1,123) = 0.19, p = 0.663). As can
Table 2. Demographic characteristics of participants and distribution of s-allele and no s-allele carri-
ers in the present sample.
LL LS/SS p
N; Hardy-Weinberg equilibrium (chi-square-test) 48 79 (65/14) .25
Age (mean (SD)) (t-test) 35.7 (13.3) 36.6 (15.8) .77
Gender (females/males) (chi-square test) 21/ 27 39/ 40 .54
doi:10.1371/journal.pone.0153089.t002
Role of 5HTTLPR Polymorphism in Pain Processing
PLOS ONE | DOI:10.1371/journal.pone.0153089 April 4, 2016 5 / 12
be seen in Fig 1, painful stimuli were rated as significantly more painful compared to the non-
painful heat stimuli (F(1,123) = 315.83, p<0.001). This was true for both s-allele as well as for
no s-allele carriers, as indicated by a non-significant interaction between “genotype” and “stim-
ulus intensity” (F(1,123) = 2.19, p = 0.142). Again, age and gender was controlled for.
Facial expression
The degree of facial expressiveness did not differ between 5-HTTLPR genotype groups (F
(1,123) = 2.01, p = 0.141). As can be seen in Fig 2, s-allele carriers were facially not more
responsive to the thermal stimulation compared to the no s-allele carriers. As expected, there
was a significant increase in facial expressions of pain from non-painful to painful heat stimu-
lation (F(1,123) = 22.11, p<0.001). This increase in facial expressions of pain did not differ
between s-allele vs. no s-allele carriers (F(1,123) = 0.36, p = 0.552). Again, age and gender was
controlled for.
Pain catastrophizing
Groups with s-allele vs. no s-allele differed significantly in the degree to which they catastro-
phize about pain (F(1,123) = 4.89, p = 0.029), when adjusting for age and gender. As can be
seen in Fig 3, s-allele carriers scored higher on the PCS scale compared to no s-allele carriers.
Fig 1. Pain thresholds and self-report ratings (VAS) (mean, SD) in s-allele and no s-allele carriers.
doi:10.1371/journal.pone.0153089.g001
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Correlations between the various factors of pain processing
As stated in the introduction, we selected different factors of pain processing and wanted to
avoid too strong redundancy between factors in order to allow independent perspectives on
pain processing. In order to test this, we computed correlations between the pain variables and
the results are given in Table 3. With the exception of a weak correlation between the two mea-
sures of subjective pain experience, namely pain threshold and supra-threshold pain ratings,
none of the other pain variables correlated significantly.
Discussion
The present study aimed at describing the association in a biallelic genetic evaluation between
the polymorphism 5-HTTLPR and various factors of pain processing in pain-free individuals.
Besides the subjective pain experience (represented by heat pain thresholds and heat pain rat-
ings), two booster factors of pain processing were also studied, namely pain catastrophizing
(questionnaire) and the facial expression of pain (FACS). These two booster factors were sup-
posed to be indicative for the emotional appraisal of pain on the one hand and the behavioral
inhibition of pain responsiveness on the other. The selected factors of pain processing have
been shown to be related to 5-HT functioning in previous studies and showed to be largely
independent from each other in the present study (as in earlier studies from our research
group [17,22]). Carriers of at least one short (s) allele in 5-HTTLPR had lower heat pain
thresholds and higher scores in the Pain Catastrophizing Scale (PCS) compared to participants
Fig 2. Facial expressions of pain (mean, SD) in response to non-painful and painful heat stimulation in s-allele and no s-allele carriers.
doi:10.1371/journal.pone.0153089.g002
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with two long alleles. In contrast, no group differences were found in subjective and facial
responses to painful heat stimulation that were tailored to the individual pain thresholds. The
two positive findings were not related to each other, given the lack of a significant correlation
between heat pain thresholds and pain catastrophizing scores.
Our finding of lower pain thresholds, indicating stronger subjective pain experience in s-
allele individuals is not corroborated by earlier studies. There are some studies with no effect of
the 5-HTTLPR polymorphism on pain thresholds [4,5,6]. In a study by Lindstedt et al. [8] indi-
viduals with at least one s-allele (SA/SA,LG/SA (triallelic analyses)) even had higher pain thresholds,
which is opposite to our results. Hooten et al. [7] found the intermediate group (LA/LG,SA/LG
(triallelic analyses)) to have the highest pain threshold. These earlier findings do not suggest that
the s-allele necessarily reduces pain thresholds. Nevertheless, there is evidence that does con-
verge with our findings of increased pain sensitivity in s-allele carriers. For example, observa-
tions in chronic pain patients have found that s-allele individuals are more prevalent in these
Fig 3. PCS scores (mean, SD) in s-allele and no s-allele carriers.
doi:10.1371/journal.pone.0153089.g003
Table 3. Correlations between the various factors of pain processing (r-values (p-values)).
Pain Threshold Supra-threshold pain ratings Pain catastrophizing
Supra-threshold pain ratings r = .295 (p = .001)
Pain catastrophizing r = -.007 (p = .940) r = .050 (p = .577)
Facial expression r = .093 (p = .298) r = .145 (p = .106) r = .170 (p = .052)
Signiﬁcant correlations are marked in bold.
doi:10.1371/journal.pone.0153089.t003
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conditions [10,23]. Moreover, healthy s-allele individuals were found to show reduced endoge-
nous pain modulation (as assessed with the Conditioned Pain Modulation (CPM) paradigm,
using a non-painful conditioning stimulus), which might render s-allele individuals more vul-
nerable to pain [24]. Furthermore, animal studies found heightened pain sensitivity in rats
with low activity of the serotonin transporter [25], which converges with our findings of
increased pain sensitivity in s-allele carriers. The lack of group differences in heat pain ratings
does not refute the hypothesis of genotype-related differences in subjective pain experience
because the intensity of supra-threshold heat stimuli was tailored to the individual heat pain
threshold and thus, might have evened out inter-individual differences in subjective pain
experience.
High scores in pain catastrophizing were also more frequent in individuals with at least one
s-allele. As said, this finding does not simply replicate the result obtained when assessing pain
thresholds because pain catastrophizing scores and pain thresholds were unrelated in the pres-
ent study. Although several studies reported significant relations between pain catastrophizing
and pain thresholds, the overall evidence is rather contradictory [26] with the degree of associa-
tion often being only weak or nonexistent [17,22]. Interestingly, it seems to make a difference,
whether one assesses dispositional pain catastrophizing (as we did) or situation-specific cata-
strophizing (catastrophic appraisal that only refers to the given noxious stimulation that one
has just experienced). Whereas situation-specific catastrophizing does indeed show associa-
tions with pain thresholds, dispositional pain catastrophizing (that we assessed) does not [27].
Thus, finding no correlation between dispositional pain catastrophizing and pain thresholds is
well in line with previous reports.
We cannot judge the reliability of our finding that s-allele individuals score higher on pain
catastrophizing because our study is the first one to investigate this. Horjales-Araujo et al. [28]
reported that a polymorphism in 5-HT receptor 3B (rs1176744) is associated with pain cata-
strophizing also using the Pain Catastrophizing Scale. This may suggest some relationship
between 5-HT functioning and pain catastrophizing. However, the genotype analyzed by Hor-
jales-Araujo et al. and the one analyzed in our study are of course not closely related in func-
tion. Nevertheless, the two findings may encourage further research on the relation between
pain catastrophizing and 5-HT functioning, also given the rich literature about relationships
between anxiety and 5-HT. Furthermore, a recent twin study found evidence for heritability of
pain catastrophizing [29] and the 5-HTTLPR genotype might be an interesting gene candidate.
The 5-HTTLPR polymorphism did not show any association with our composite parameter
of the facial expression of pain. We expected such an association because the facial expression
of pain is not only driven by the intensity of pain, which might already be determined by 5-HT
related mechanisms, but is also controlled by inhibitory gating of behavioral impulses [14,15].
We could recently provide evidence that the facial expression of pain is correlated with motor
inhibitory control and supervised by frontostriatal circuits in the brain with inhibitory function
[14,15]. Although motor impulse control appeared to be related in one study with the s-allele
in 5-HTTLPR [13], our hypothesis of a relationship between the 5-HTTLPR polymorphism
and the facial expression of pain could clearly not be verified. This does not, however, exclude
that other 5-HT related mechanisms may play a role in the control of the facial expression of
pain.
According to our data, s-allele carriers may experience more pain under conditions of a sim-
ilar noxious load and may additionally and independently boost the processing of pain by cata-
strophic thinking. These two mechanisms of action may qualify the s-allele in 5-HTTLPR as a
substantial risk factor for the development of pain problems. However, the effects were rather
small and require replication before far-reaching conclusions can be drawn.
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Some limitations ought to be mentioned. For studying genotype-phenotype associations
and potential moderator effects of phenotypes amongst each other, which might have been
considered for the present research questions, the sample size is still limited. However, the
enormous investment of time and effort to FACS code the facial expression of pain will likely
prevent larger samples even in future studies. Three domains of pain processing were in the
focus of interest, namely subjective pain experience, emotional appraisal and motor/facial
responsiveness. The number of measures used within each of these three domains, however,
was rather limited. For example, we used pain intensities that were tailored to the individual
pain thresholds and thus, the variability in pain ratings and in facial responses was artificially
constricted, which might have impacted the genetic associations with these pain responses.
Also, selecting only one pain modality limits the findings, since genetic associations often differ
across modalities. Moreover, it would have been valuable to have also included measures of
positive and negative mood, depression and/or anxiety, given the role of serotonin in mood
and affective disorders [30, 31] and the seeming role of mood in pain processing. Thus, wider
operationalization for each of the three domains (with additional measures) would have been
preferable
In summary, the polymorphism 5-HTTLPR appeared to affect the subjective pain experi-
ence and the tendency to catastrophize about pain because s-allele carrier presented with lower
pain thresholds and higher scores of pain catastrophizing, two variables that were unrelated in
the present study. The facial expression of pain showed no association with 5-HT functioning
as indicated by the present genetic evaluation. The present data suggest that the polymorphism
5-HTTLPR may affect the development and maintenance of pain via two independent routes,
the sensory processes of subjective pain experiences and the booster effects of pain
catastrophizing.
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